fbpx

News & Press


Promising Phase II Results for New Drug to Treat Advanced Melanoma

November 5, 2010

Roche announced results from a Phase II clinical study of RG7204 (PLX4032), an inhibitor targeting the BRAF protein that is found in half of metastatic melanoma tumors.  The promising data was presented at the seventh International Melanoma Resear …



FDA Extends Deadline for Decision on Ipilimumab

November 3, 2010

The U.S Food and Drug Administration (FDA) extended its deadline for an approval decision on Bristol-Myers Squibb’s (BMS) drug for advanced melanoma, ipilimumab.  The FDA was expected to reach a decision by December 25, 2010 but has delayed …



Melanoma Research Gets Boost from Washington, D.C. Patients and Party-goers

November 2, 2010

WASHINGTON, D.C.— For years, treatment options for patients with advanced melanoma have been bleak, with survival averaging around one year after diagnosis.  But as the research community hones in on treatments that may be the first to impro …



MRF to Young Adults: Debunk Melanoma Myths To Increase Survival Odds

October 20, 2010

WASHINGTON, D.C.—Melanoma’s role as the number one form of cancer in young adults may be fueled by pervasive myths and misunderstandings about risk factors, and ways to detect and treat the disease. In 2010 alone, nearly 69,000 America …



Respected Producer/Writer Succumbs to Melanoma

October 7, 2010

The Melanoma Research Foundation (MRF) is deeply saddened to learn of the loss of famed Hollywood producer and writer Stephen J. Cannell, who recently passed away from complications associated with melanoma.  Credited with producing favorites …